Activation of MAPK1/2, also referred to as extracellular signal-regulated-kinases ERK1 (p44) and ERK2 (p42), and AKT can ultimately increase breast cancer cell proliferation [21] and survival [22,23]. Here, MAPK1 is linked to breast carcinoma.